FROM Aaron Kesselheim
An old drug gets a ridiculously high price….again Are incentives for so-called "orphan drugs" being misused to jack up the price of one medication by 4000 percent? Photo by Chris Potter A rare form of muscular dystrophy has long been treated in the US by a steroid imported from overseas at a price of $1200 a year. Now the FDA has approved its manufacture and distribution in this country by the drug company Marathon. The new price is $89,000 a year — reduced to $54,000 after rebates and discounts. We get perspective from Carolyn Johnson, who covers the business of medicine for the Washington Post , and Dr. Aaron Kesselheim, a professor of medicine at Harvard, where he's also Director of the program on Regulation, Therapeutics and Law.
Doctors, Drug Companies and Transparency In an effort to get doctors to prescribe their drugs to patients, drug makers spend billions of dollars a year on meals, speaking and consulting fees, and other perks for physicians. Today, a new government database goes online that will list the money pharmaceutical companies spend on doctors.
What is Trump's plan for Middle East peace? On his first foreign tour, President Trump has promised "peace" between Israel and the Palestinians. Are there any details for re-starting talks that have been stalled for the past three years?
Concern deepens amid Trump's controversies President Trump delivered today's commencement speech to the Coast Guard Academy in Connecticut. As he praised the accomplishments of the graduates, he listed some of his own… and made reference to reports that he leaked intelligence to the Russians and tried to shut down an FBI Investigation into his associates.
Trump fires FBI Director James Comey Vice President Mike Pence took the Administration's lead today in explaining why the President fired the Head of the FBI, saying, "The president made the right decision at the right time." Trump's action is being compared to the so-called "Saturday Night Massacre" that led to President Richard Nixon's resignation in 1973.
The free-flowing leaks in the Trump White House President Obama tried to clamp down on leakers, but the Trump Administration is besieged almost as never before. Are the "anonymous sources" partisans or worried professionals? Are they endangering the republic or performing a public service?